Department of Urology, Pitié-Salpêtrière Hospital, Pierre and Marie Curie Medical School, Paris VI, Paris, France.
BJU Int. 2011 May;107(10):1618-26. doi: 10.1111/j.1464-410X.2010.09610.x. Epub 2010 Aug 25.
Artificial urinary sphincter (AUS) implantation is one of several surgical options for the treatment of female stress urinary incontinence. It is indicated for women with both clinically and urodynamically defined intrinsic sphincter deficiency that significantly affects quality of life. The erosion/revision risk increases after several previous surgical interventions. Therefore, women believed to be candidates for AUS implantation should be rapidly (after the failure of a maximum of two previous surgical procedures) referred to specialized centres, where the knowledge and experience concerning the diagnosis, surgery and management of female stress urinary incontinence is concentrated. To refer correctly, non-academic urologists/gynaecologists should also be well informed about AUS implantation. Only in this way can the patient weigh the high long-term success rate and high quality of life improvement of AUS implantation against the greater complication/revision risk and take a well-considered decision.
人工尿道括约肌（AUS）植入术是治疗女性压力性尿失禁的几种手术选择之一。它适用于那些存在临床和尿动力学定义的内在括约肌缺陷、严重影响生活质量的女性。在多次先前的手术干预后，发生侵蚀/修复风险会增加。因此，被认为是 AUS 植入候选者的女性应尽快（在最多两次先前手术失败后）转介到专门中心，在那里集中了关于女性压力性尿失禁的诊断、手术和管理的知识和经验。为了正确转诊，非学术泌尿科医生/妇科医生也应该充分了解 AUS 植入术。只有这样，患者才能权衡 AUS 植入术的高长期成功率和生活质量改善与更高的并发症/修复风险，并做出深思熟虑的决策。
